ChartRow logo
AXSM
Axsome Therapeutics Inc.Stock · Health Care · Russell 2000 0.2%
$213.63−$1.03 (-0.48%)as of market close, Aug 13, 2026
☾ After hours:$213.68+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

AXSM financial statements

The full income statement, balance sheet, and cash-flow statement for Axsome Therapeutics Inc. (AXSM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 48.0M2024-09 48.5M2024-12 48.8M2025-03 49.2M2025-06 49.9M2025-09 50.4M2025-12 51.2M2026-03 51.5M2026-06 52.4M+9.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
638M
YoY+65.5%
386M
YoY+42.5%
271M
YoY+440.8%
50.0M
Cost of revenue
5.20M
125M
YoY+25.8%
Operating income
-167M
YoY+40.6%
-281M
YoY-21.0%
-232M
YoY-28.9%
-180M
YoY-44.2%
-125M
YoY-25.8%
Interest expense
-15.9M
YoY+26.2%
-21.6M
YoY-7.7%
-20.0M
YoY-107.4%
-9.66M
Interest & investment income
9.37M
YoY-37.6%
15.0M
YoY+10.5%
13.6M
YoY+484.4%
2.32M
Pre-tax income
-184M
YoY+36.0%
-287M
YoY-20.5%
-238M
YoY-27.3%
-187M
YoY-43.5%
-130M
Income tax
-530K
YoY-723.5%
85.0K
YoY-91.1%
960K
0.00
0.00
Net income
-183M
YoY+36.2%
-287M
YoY-20.1%
-239M
YoY-27.8%
-187M
YoY-43.5%
-130M
YoY-26.7%
-$3.68
YoY+38.6%
-$5.99
YoY-13.7%
-$5.27
YoY-14.6%
-$4.60
YoY-32.6%
-$3.47
YoY-25.3%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
589M
YoY+21.4%
485M
YoY-3.8%
504M
YoY+105.3%
246M
YoY+183.9%
86.5M
YoY-53.0%
690M
YoY+21.3%
568M
YoY-3.4%
588M
YoY+77.5%
331M
YoY+277.6%
87.8M
YoY-52.8%
379M
YoY+64.6%
230M
YoY+65.7%
139M
YoY+43.8%
96.6M
YoY+318.6%
23.1M
YoY-1.6%
602M
YoY+17.6%
511M
YoY+28.8%
397M
YoY+79.0%
222M
YoY+207.6%
72.2M
YoY-0.3%
88.3M
YoY+54.9%
57.0M
YoY-70.1%
191M
YoY+74.3%
110M
YoY+600.9%
15.6M
YoY-86.3%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-93.4M
YoY+27.3%
-128M
YoY+11.5%
-145M
YoY-24.5%
-117M
YoY-7.7%
-108M
YoY-37.9%
-480K
YoY-77.8%
-270K
YoY+53.6%
-582K
YoY+98.9%
-53.7M
YoY-17335.7%
-308K
YoY-571.2%
101M
YoY+75.4%
57.8M
YoY-82.5%
331M
YoY+16.3%
285M
YoY+2456.9%
11.1M
YoY-73.8%
Net change in cash
7.58M
YoY+110.7%
-70.8M
YoY-138.2%
185M
YoY+62.1%
114M
YoY+217.4%
-97.4M
YoY-169.9%
Interest paid
14.6M
YoY-25.7%
19.7M
YoY+17.7%
16.7M
YoY+117.7%
7.69M
YoY+66.2%
4.63M
YoY+120.5%
Income taxes paid
-180K
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
9.34B
YoY+126.4%
4.13B
YoY+9.6%
3.77B
YoY+12.4%
3.35B
YoY+130.4%
1.45B
YoY-52.3%
P/S
14.6×
YoY+36.8%
10.7×
YoY-36.5%
16.9×
P/B
105.8×
YoY+46.2%
72.4×
YoY+417.9%
14.0×
YoY-34.3%
21.3×
YoY-77.1%
93.0×
YoY+247.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: AXSM's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AXSM filings on SEC EDGAR → Not investment advice.